KEAP1 and renal fibrosis: Therefore, our study revealed that activation of the impaired Keap1/Nrf2 signaling pathway might be also a potential molecular mechanism of anti-oxidant and anti-inflammatory bioactivities of both SKI and three anthraquinones against renal fibrosis.